In Utero — Execution
Funds United Kingdom stillbirth-reduction initiatives with prenatal intervention and translational implementation support.
In Utero is a $50 million Wellcome Leap program directed by Sarah Stock, MD, PhD, Professor and Consultant in Maternal and Fetal Health with expertise in stillbirth and preterm birth. The program's central goal is to cut global stillbirth rates in half by creating scalable, non-invasive methods to measure, model, and predict gestational development in utero. The urgency of the problem is quantifie…
Scalable non-invasive measurement and prediction of gestational development in utero, with the goal of cutting the global stillbirth rate in half by improving early identification of at-risk pregnancies.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility